脳幹オーラ薬と片頭痛の世界市場:市場規模・現状・予測(2019-2025)

【英語タイトル】Global Migraine With Brainstem Aura Drugs Market Size, Status and Forecast 2019-2025

QYResearchが出版した調査資料(QYR9055272)・商品コード:QYR9055272
・発行会社(調査会社):QYResearch
・発行日:2019年8月7日(※2024年版があります。お問い合わせください)
・ページ数:95
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療・製薬・バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当資料は、脳幹オーラ薬と片頭痛のグローバル市場について調査・分析したレポートで、種類別(中絶薬、予防薬)、用途別(小売薬局、病院薬局、その他)、主要地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米)の市場規模、市場予測、関連企業情報などが含まれています。

・脳幹オーラ薬と片頭痛の世界市場規模
・主要企業別市場シェア
・脳幹オーラ薬と片頭痛の世界市場規模:種類別(中絶薬、予防薬)
・脳幹オーラ薬と片頭痛の世界市場規模:用途別(小売薬局、病院薬局、その他)
・脳幹オーラ薬と片頭痛のアメリカ市場規模(種類別、用途別)
・脳幹オーラ薬と片頭痛のヨーロッパ市場規模(種類別、用途別)
・脳幹オーラ薬と片頭痛の中国市場規模(種類別、用途別)
・脳幹オーラ薬と片頭痛の日本市場規模(種類別、用途別)
・脳幹オーラ薬と片頭痛の東南アジア市場規模(種類別、用途別)
・脳幹オーラ薬と片頭痛のインド市場規模(種類別、用途別)
・脳幹オーラ薬と片頭痛の中南米市場規模(種類別、用途別)
・主要企業別分析(企業概要、製品動向、販売量など)
・脳幹オーラ薬と片頭痛の世界市場予測(2019年-2025年)
・脳幹オーラ薬と片頭痛の地域別市場予測(2019年-2025年)
...
【レポートの概要】

A migraine with brainstem aura is also known as a basilar migraine or basilar artery migraine. It is a rare type of a migraine that begins in the base of the brain (brain stem). A migraine with brainstem aura occurs in about 1.5% of the patients suffering from with a headache. This migraine can occur in men and women of all ages.Geographically, the Americas is anticipated to dominate the global migraine with brainstem aura market owing to a well-developed healthcare sector, rising prevalence of migraine and growing healthcare expenditure.
In 2018, the global Migraine With Brainstem Aura Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Migraine With Brainstem Aura Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Migraine With Brainstem Aura Drugs development in United States, Europe and China.

The key players covered in this study
Pfizer
GlaxoSmithKline
Abbott Laboratories
Eli Lily
Johnson & Johnson
AstraZeneca
Eisai
Allergen
Merck
Endo International
Impax Laboratories

Market segment by Type, the product can be split into
Abortive Medication
Preventive Medication

Market segment by Application, split into
Retail Pharmacies
Hospital Pharmacies
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Migraine With Brainstem Aura Drugs status, future forecast, growth opportunity, key market and key players.
To present the Migraine With Brainstem Aura Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Migraine With Brainstem Aura Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Migraine With Brainstem Aura Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Abortive Medication
1.4.3 Preventive Medication
1.5 Market by Application
1.5.1 Global Migraine With Brainstem Aura Drugs Market Share by Application (2014-2025)
1.5.2 Retail Pharmacies
1.5.3 Hospital Pharmacies
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Migraine With Brainstem Aura Drugs Market Size
2.2 Migraine With Brainstem Aura Drugs Growth Trends by Regions
2.2.1 Migraine With Brainstem Aura Drugs Market Size by Regions (2014-2025)
2.2.2 Migraine With Brainstem Aura Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Migraine With Brainstem Aura Drugs Market Size by Manufacturers
3.1.1 Global Migraine With Brainstem Aura Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Migraine With Brainstem Aura Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Migraine With Brainstem Aura Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Migraine With Brainstem Aura Drugs Key Players Head office and Area Served
3.3 Key Players Migraine With Brainstem Aura Drugs Product/Solution/Service
3.4 Date of Enter into Migraine With Brainstem Aura Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Migraine With Brainstem Aura Drugs Market Size by Type (2014-2019)
4.2 Global Migraine With Brainstem Aura Drugs Market Size by Application (2014-2019)

5 United States
5.1 United States Migraine With Brainstem Aura Drugs Market Size (2014-2019)
5.2 Migraine With Brainstem Aura Drugs Key Players in United States
5.3 United States Migraine With Brainstem Aura Drugs Market Size by Type
5.4 United States Migraine With Brainstem Aura Drugs Market Size by Application

6 Europe
6.1 Europe Migraine With Brainstem Aura Drugs Market Size (2014-2019)
6.2 Migraine With Brainstem Aura Drugs Key Players in Europe
6.3 Europe Migraine With Brainstem Aura Drugs Market Size by Type
6.4 Europe Migraine With Brainstem Aura Drugs Market Size by Application

7 China
7.1 China Migraine With Brainstem Aura Drugs Market Size (2014-2019)
7.2 Migraine With Brainstem Aura Drugs Key Players in China
7.3 China Migraine With Brainstem Aura Drugs Market Size by Type
7.4 China Migraine With Brainstem Aura Drugs Market Size by Application

8 Japan
8.1 Japan Migraine With Brainstem Aura Drugs Market Size (2014-2019)
8.2 Migraine With Brainstem Aura Drugs Key Players in Japan
8.3 Japan Migraine With Brainstem Aura Drugs Market Size by Type
8.4 Japan Migraine With Brainstem Aura Drugs Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Migraine With Brainstem Aura Drugs Market Size (2014-2019)
9.2 Migraine With Brainstem Aura Drugs Key Players in Southeast Asia
9.3 Southeast Asia Migraine With Brainstem Aura Drugs Market Size by Type
9.4 Southeast Asia Migraine With Brainstem Aura Drugs Market Size by Application

10 India
10.1 India Migraine With Brainstem Aura Drugs Market Size (2014-2019)
10.2 Migraine With Brainstem Aura Drugs Key Players in India
10.3 India Migraine With Brainstem Aura Drugs Market Size by Type
10.4 India Migraine With Brainstem Aura Drugs Market Size by Application

11 Central & South America
11.1 Central & South America Migraine With Brainstem Aura Drugs Market Size (2014-2019)
11.2 Migraine With Brainstem Aura Drugs Key Players in Central & South America
11.3 Central & South America Migraine With Brainstem Aura Drugs Market Size by Type
11.4 Central & South America Migraine With Brainstem Aura Drugs Market Size by Application

12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Migraine With Brainstem Aura Drugs Introduction
12.1.4 Pfizer Revenue in Migraine With Brainstem Aura Drugs Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 GlaxoSmithKline
12.2.1 GlaxoSmithKline Company Details
12.2.2 Company Description and Business Overview
12.2.3 Migraine With Brainstem Aura Drugs Introduction
12.2.4 GlaxoSmithKline Revenue in Migraine With Brainstem Aura Drugs Business (2014-2019)
12.2.5 GlaxoSmithKline Recent Development
12.3 Abbott Laboratories
12.3.1 Abbott Laboratories Company Details
12.3.2 Company Description and Business Overview
12.3.3 Migraine With Brainstem Aura Drugs Introduction
12.3.4 Abbott Laboratories Revenue in Migraine With Brainstem Aura Drugs Business (2014-2019)
12.3.5 Abbott Laboratories Recent Development
12.4 Eli Lily
12.4.1 Eli Lily Company Details
12.4.2 Company Description and Business Overview
12.4.3 Migraine With Brainstem Aura Drugs Introduction
12.4.4 Eli Lily Revenue in Migraine With Brainstem Aura Drugs Business (2014-2019)
12.4.5 Eli Lily Recent Development
12.5 Johnson & Johnson
12.5.1 Johnson & Johnson Company Details
12.5.2 Company Description and Business Overview
12.5.3 Migraine With Brainstem Aura Drugs Introduction
12.5.4 Johnson & Johnson Revenue in Migraine With Brainstem Aura Drugs Business (2014-2019)
12.5.5 Johnson & Johnson Recent Development
12.6 AstraZeneca
12.6.1 AstraZeneca Company Details
12.6.2 Company Description and Business Overview
12.6.3 Migraine With Brainstem Aura Drugs Introduction
12.6.4 AstraZeneca Revenue in Migraine With Brainstem Aura Drugs Business (2014-2019)
12.6.5 AstraZeneca Recent Development
12.7 Eisai
12.7.1 Eisai Company Details
12.7.2 Company Description and Business Overview
12.7.3 Migraine With Brainstem Aura Drugs Introduction
12.7.4 Eisai Revenue in Migraine With Brainstem Aura Drugs Business (2014-2019)
12.7.5 Eisai Recent Development
12.8 Allergen
12.8.1 Allergen Company Details
12.8.2 Company Description and Business Overview
12.8.3 Migraine With Brainstem Aura Drugs Introduction
12.8.4 Allergen Revenue in Migraine With Brainstem Aura Drugs Business (2014-2019)
12.8.5 Allergen Recent Development
12.9 Merck
12.9.1 Merck Company Details
12.9.2 Company Description and Business Overview
12.9.3 Migraine With Brainstem Aura Drugs Introduction
12.9.4 Merck Revenue in Migraine With Brainstem Aura Drugs Business (2014-2019)
12.9.5 Merck Recent Development
12.10 Endo International
12.10.1 Endo International Company Details
12.10.2 Company Description and Business Overview
12.10.3 Migraine With Brainstem Aura Drugs Introduction
12.10.4 Endo International Revenue in Migraine With Brainstem Aura Drugs Business (2014-2019)
12.10.5 Endo International Recent Development
12.11 Impax Laboratories

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Migraine With Brainstem Aura Drugs Key Market Segments
Table Key Players Migraine With Brainstem Aura Drugs Covered
Table Global Migraine With Brainstem Aura Drugs Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Migraine With Brainstem Aura Drugs Market Size Market Share by Type 2014-2025
Figure Abortive Medication Figures
Table Key Players of Abortive Medication
Figure Preventive Medication Figures
Table Key Players of Preventive Medication
Table Global Migraine With Brainstem Aura Drugs Market Size Growth by Application 2014-2025 (Million US$)
Figure Retail Pharmacies Case Studies
Figure Hospital Pharmacies Case Studies
Figure Others Case Studies
Figure Migraine With Brainstem Aura Drugs Report Years Considered
Table Global Migraine With Brainstem Aura Drugs Market Size 2014-2025 (Million US$)
Figure Global Migraine With Brainstem Aura Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Migraine With Brainstem Aura Drugs Market Size by Regions 2014-2025 (Million US$)
Table Global Migraine With Brainstem Aura Drugs Market Size by Regions 2014-2019 (Million US$)
Table Global Migraine With Brainstem Aura Drugs Market Share by Regions 2014-2019
Figure Global Migraine With Brainstem Aura Drugs Market Share by Regions 2014-2019
Figure Global Migraine With Brainstem Aura Drugs Market Share by Regions 2019
Table Market Top Trends
Table Global Migraine With Brainstem Aura Drugs Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Migraine With Brainstem Aura Drugs Market Share by Manufacturers (2014-2019)
Figure Global Migraine With Brainstem Aura Drugs Market Share by Manufacturers in 2018
Table Global Migraine With Brainstem Aura Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Migraine With Brainstem Aura Drugs Product/Solution/Service
Table Date of Enter into Migraine With Brainstem Aura Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Migraine With Brainstem Aura Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Migraine With Brainstem Aura Drugs Market Size Share by Type (2014-2019)
Figure Global Migraine With Brainstem Aura Drugs Market Size Market Share by Type (2014-2019)
Table Global Migraine With Brainstem Aura Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Migraine With Brainstem Aura Drugs Market Size Share by Application (2014-2019)
Figure Global Migraine With Brainstem Aura Drugs Market Size Market Share by Application (2014-2019)
Figure Global Migraine With Brainstem Aura Drugs Revenue Market Share by Application in 2018
Figure United States Migraine With Brainstem Aura Drugs Market Size 2014-2019 (Million US$)
Table United States Key Players Migraine With Brainstem Aura Drugs Revenue (2018-2019) (Million US$)
Table United States Key Players Migraine With Brainstem Aura Drugs Market Share (2018-2019)
Table United States Migraine With Brainstem Aura Drugs Market Size by Type (2014-2019) (Million US$)
Table United States Migraine With Brainstem Aura Drugs Market Share by Type (2014-2019)
Table United States Migraine With Brainstem Aura Drugs Market Size by Application (2014-2019) (Million US$)
Table United States Migraine With Brainstem Aura Drugs Market Share by Application (2014-2019)
Figure Europe Migraine With Brainstem Aura Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Migraine With Brainstem Aura Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Migraine With Brainstem Aura Drugs Market Share (2018-2019)
Table Europe Migraine With Brainstem Aura Drugs Market Size by Type (2014-2019) (Million US$)
Table Europe Migraine With Brainstem Aura Drugs Market Share by Type (2014-2019)
Table Europe Migraine With Brainstem Aura Drugs Market Size by Application (2014-2019) (Million US$)
Table Europe Migraine With Brainstem Aura Drugs Market Share by Application (2014-2019)
Figure China Migraine With Brainstem Aura Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Migraine With Brainstem Aura Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Migraine With Brainstem Aura Drugs Market Share (2018-2019)
Table China Migraine With Brainstem Aura Drugs Market Size by Type (2014-20189) (Million US$)
Table China Migraine With Brainstem Aura Drugs Market Share by Type (2014-2019)
Table China Migraine With Brainstem Aura Drugs Market Size by Application (2014-2019) (Million US$)
Table China Migraine With Brainstem Aura Drugs Market Share by Application (2014-2019)
Figure Japan Migraine With Brainstem Aura Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Migraine With Brainstem Aura Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Migraine With Brainstem Aura Drugs Market Share (2018-2019)
Table Japan Migraine With Brainstem Aura Drugs Market Size by Type (2014-2019) (Million US$)
Table Japan Migraine With Brainstem Aura Drugs Market Share by Type (2014-2019)
Table Japan Migraine With Brainstem Aura Drugs Market Size by Application (2014-2019) (Million US$)
Table Japan Migraine With Brainstem Aura Drugs Market Share by Application (2014-2019)
Figure Southeast Asia Migraine With Brainstem Aura Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Migraine With Brainstem Aura Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Migraine With Brainstem Aura Drugs Market Share (2018-2019)
Table Southeast Asia Migraine With Brainstem Aura Drugs Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Migraine With Brainstem Aura Drugs Market Share by Type (2014-2019)
Table Southeast Asia Migraine With Brainstem Aura Drugs Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Migraine With Brainstem Aura Drugs Market Share by Application (2014-2019)
Figure India Migraine With Brainstem Aura Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Migraine With Brainstem Aura Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Migraine With Brainstem Aura Drugs Market Share (2018-2019)
Table India Migraine With Brainstem Aura Drugs Market Size by Type (2014-2019) (Million US$)
Table India Migraine With Brainstem Aura Drugs Market Share by Type (2014-2019)
Table India Migraine With Brainstem Aura Drugs Market Size by Application (2014-2019) (Million US$)
Table India Migraine With Brainstem Aura Drugs Market Share by Application (2014-2019)
Figure Central & South America Migraine With Brainstem Aura Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Migraine With Brainstem Aura Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Migraine With Brainstem Aura Drugs Market Share (2018-2019)
Table Central & South America Migraine With Brainstem Aura Drugs Market Size by Type (2014-2019) (Million US$)
Table Central & South America Migraine With Brainstem Aura Drugs Market Share by Type (2014-2019)
Table Central & South America Migraine With Brainstem Aura Drugs Market Size by Application (2014-2019) (Million US$)
Table Central & South America Migraine With Brainstem Aura Drugs Market Share by Application (2014-2019)
Table Pfizer Company Details
Table Pfizer Revenue in Migraine With Brainstem Aura Drugs Business (2014-2019) (Million US$)
Figure Pfizer Revenue Growth Rate in Migraine With Brainstem Aura Drugs Business (2014-2019)
Table Pfizer Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Migraine With Brainstem Aura Drugs Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Migraine With Brainstem Aura Drugs Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Abbott Laboratories Company Details
Table Abbott Laboratories Revenue in Migraine With Brainstem Aura Drugs Business (2014-2019)(Million US$)
Figure Abbott Laboratories Revenue Growth Rate in Migraine With Brainstem Aura Drugs Business (2014-2019)
Table Abbott Laboratories Recent Development
Table Eli Lily Company Details
Table Eli Lily Revenue in Migraine With Brainstem Aura Drugs Business (2014-2019)(Million US$)
Figure Eli Lily Revenue Growth Rate in Migraine With Brainstem Aura Drugs Business (2014-2019)
Table Eli Lily Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Migraine With Brainstem Aura Drugs Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Migraine With Brainstem Aura Drugs Business (2014-2019)
Table Johnson & Johnson Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Migraine With Brainstem Aura Drugs Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Migraine With Brainstem Aura Drugs Business (2014-2019)
Table AstraZeneca Recent Development
Table Eisai Company Details
Table Eisai Revenue in Migraine With Brainstem Aura Drugs Business (2014-2019)(Million US$)
Figure Eisai Revenue Growth Rate in Migraine With Brainstem Aura Drugs Business (2014-2019)
Table Eisai Recent Development
Table Allergen Company Details
Table Allergen Revenue in Migraine With Brainstem Aura Drugs Business (2014-2019)(Million US$)
Figure Allergen Revenue Growth Rate in Migraine With Brainstem Aura Drugs Business (2014-2019)
Table Allergen Recent Development
Table Merck Company Details
Table Merck Revenue in Migraine With Brainstem Aura Drugs Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Migraine With Brainstem Aura Drugs Business (2014-2019)
Table Merck Recent Development
Table Endo International Company Details
Table Endo International Revenue in Migraine With Brainstem Aura Drugs Business (2014-2019)(Million US$)
Figure Endo International Revenue Growth Rate in Migraine With Brainstem Aura Drugs Business (2014-2019)
Table Endo International Recent Development
Table Impax Laboratories Company Details
Table Global Migraine With Brainstem Aura Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Migraine With Brainstem Aura Drugs Market Size Share by Regions (2019-2025)
Figure Global Migraine With Brainstem Aura Drugs Market Size Share by Regions in 2025
Figure United States Migraine With Brainstem Aura Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Migraine With Brainstem Aura Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Migraine With Brainstem Aura Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Migraine With Brainstem Aura Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Migraine With Brainstem Aura Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Migraine With Brainstem Aura Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Migraine With Brainstem Aura Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Migraine With Brainstem Aura Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Migraine With Brainstem Aura Drugs Market Size by Product (2019-2025)
Figure Global Migraine With Brainstem Aura Drugs Market Size by Product in 2025
Table Global Migraine With Brainstem Aura Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Migraine With Brainstem Aura Drugs Market Size by Application (2019-2025)
Figure Global Migraine With Brainstem Aura Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


★調査レポート[脳幹オーラ薬と片頭痛の世界市場:市場規模・現状・予測(2019-2025)] (コード:QYR9055272)販売に関する免責事項を必ずご確認ください。
★調査レポート[脳幹オーラ薬と片頭痛の世界市場:市場規模・現状・予測(2019-2025)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆